ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

Heidelberger Wins $100,000 Award

September 17, 1982

CCIRC Considers Programs Involved with Including Multimodality Studies

October 10, 1975

Four New CCOPs Awarded To Fill Geographical Gaps – Mississippi, Ft. Worth, Fresno, Vermont

September 16, 1983

NCI To Invite Unaffiliated Oncologists To Enroll Patients On Phase III Trials

May 10, 2002

First Mobil NMR Scanner Goes Into Operation At Temple

June 22, 1984

No Site Visit For Georgetown Lombardi as Federal Government Shuts Down

October 4, 2013